A detailed history of Bank Of America Corp transactions in Alvotech stock. As of the latest transaction made, Bank Of America Corp holds 13,563 shares of ALVO stock, worth $161,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,563
Previous 20,219 32.92%
Holding current value
$161,535
Previous $245,000 34.29%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.76 - $12.99 $71,618 - $86,461
-6,656 Reduced 32.92%
13,563 $161,000
Q2 2024

Aug 14, 2024

BUY
$11.4 - $14.51 $116,496 - $148,277
10,219 Added 102.19%
20,219 $245,000
Q4 2023

Feb 14, 2024

SELL
$8.55 - $11.48 $42,750 - $57,400
-5,000 Reduced 33.33%
10,000 $114,000
Q2 2023

Aug 14, 2023

SELL
$6.9 - $13.85 $966 - $1,939
-140 Reduced 0.92%
15,000 $116,000
Q1 2023

May 12, 2023

BUY
$10.01 - $14.03 $151,551 - $212,414
15,140 New
15,140 $195,000

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $2.96B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.